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Role of precipitating and nonprecipitating antibodies in
glomerular immune complex formation
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Role of precipitating and nonprecipitating antibodies In glomerular
immune complex formation. The present study compared directly the
ability of precipitating and nonprecipitating antibodies to form and
sustain glomerular immune deposits. The antigen phenylated gelatin(DNP-GL) was injected i.v. into rats. DNP-GL is cleared from the
circulation rapidly and becomes localized in glomeruli. Two hours later,
rats received either precipitating or nonprecipitating mouse monoclonal
anti-DNP antibodies. These antibodies were comparable with respect to
size, affinity, number of antigen combining sites and isoelectric point.
However, in vitro, nonprecipitating antibodies demonstrated a faster
dissociation rate from antigen than precipitating antibodies. Control
rats received DNP-GL alone or antibody alone. Antibody deposition in
glomeruli was quantitated by Computerized Image Analysis (CIA) of
immunoperoxidase stained tissue sections and by glomerular radioac-
tive counts in experiments using 125! labelled antibodies. We demon-
strated that glomerular uptake of anti-DNP antibody was similar two
hours after injection of precipitating and nonprecipitating antibodies.
However, six or more hours after injection, significantly less antibody
was present in the glomeruli of rats injected with nonprecipitating
antibodies. These differences could not be explained by a greater rate of
antigen removal from kidney in rats injected with nonprecipitating
antibodies. To assess whether nonprecipitating antibodies modify the
glomerular binding and retention of precipitating antibody, in a separate
series of experiments rats were injected with equal amounts of precip-
itating and nonprecipitating antibodies. Both types of antibody bound to
glomeruli. However, with time glomerular antibody levels paralleled
those found in rats injected with nonprecipitating antibody alone. We
conclude that the precipitating characteristics of antibodies do not
affect their ability to deposit in kidney. However, precipitating antibod-
ies are retained longer in glomerular immune deposits. The coadmin-
istration of precipitating and nonprecipitating antibodies results in
removal of antibodies from glomeruli at a rate similar to that demon-
strated with nonprecipitating antibodies. This study suggest that im-
mune responses that foster the development of a nonprecipitating
antibody response are less likely to be nephritogenic.
There are several lines of evidence to suggest that in the
pathogenesis of IC mediated glomerulonephritis, nonprecipitat-
ing antibodies may be less pathogenic than precipitating anti-
bodies. For example, in the classic studies of chronic serum
sickness in the rabbit, it was found that animals that formed
only, or mainly, nonprecipitating antibodies generally devel-
oped mild disease and only after prolonged administration of
antigen. By contrast, animals that developed high levels of
precipitating antibodies generally developed severe disease that
was relatively early in onset [1, 2]. Similarly, in studies involv-
ing the infusion of preformed IC, it was found that soluble IC
were less likely to deposit and to persist in glomeruli compared
to IC with limited solubility [3]. However, in those latter studies
it is difficult to separate the role of IC size versus the role of IC
precipitabiity. Agodoa, Gauthier and Mannik [4] have evalu-
ated in situ glomerular IC formation by precipitating or non-
precipitating IC systems. In those studies, cationized antigen
was localized in glomeruli. The precipitating characteristics of
the IC were determined by modifications in the number of
hapten sites in the antigen. In those studies, IC formed with
nonprecipitating antigen were removed from the glomerulus
faster than IC formed with precipitating antigen. Similarly,
nonprecipitating antigen was removed faster from the glomer-
ulus than precipitating antigen. Thus, those studies support the
notion that the precipitating characteristic of IC are pathogen-
ically important. However, the role of antibody precipitating
characteristics was not clarified by those studies.
In the present study we evaluated directly the role of anti-
body precipitating characteristics on a model of in situ glomer-
ular IC formation. In the model used, antigen administered
intravenously localized in the glomerular mesangium due to the
capacity of the antigen to bind to mesangial fibronectin [5].
Once the antigen was bound to the glomerulus, rats received
injections of mouse monoclonal antibodies with variable pre-
cipitating characteristics. The biophysical characteristics of the
antibodies used in the present study have been studied in our
laboratory in the recent past [6]. These mouse monoclonal
anti-DNP antibodies differ in isotype and precipitating charac-
teristics. However, precipitating and nonprecipitating anti-DNP
antibodies do not differ in their affinity for the antigen, number
of antigenic combining sites or isoelectric point. Finally, in the
present study, we utilized Computerized Image Analysis (CIA)
of immunoperoxidase stained tissue sections to quantitate the
amount of antibody present in the glomerulus. CIA has been
used previously for quantitation of tissue antigens in other
experimental systems [7].
Methods
Preparation of antigen and monoclonal antibodies
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The antigen used in the present studies was phenylated
gelatin (DNP-GL). The gelatin portion of this antigen binds
avidly to mesangial fibronectin, thus permitting the localization
of DNP-GL in the glomerular mesangium [5]. The DNP portion
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of DNP-GL serves as an antigenic site. The DNP-GL prepara-
tion used in the present study had an average of 15 DNP groups
per gelatin molecule. In some studies, DNP-GL was radiola-
belled with 125j by the IODO-GEN method (Pierce). The same
iodination method was used for other proteins. Incubation with
different concentrations of precipitating monoclonal IgGi anti-
DNP antibody resulted in a maximum of 65% precipitation of
DNPI5-GL.
We have previously described the methods used for the
preparation and characterization of mouse monoclonal anti-
DNP antibodies [6]. In the present study two anti-DNP anti-
bodies were used: a precipitating IgGi antibody and a nonpre-
cipitating IgG2b antibody. Both antibodies were purified by
caprylic acid followed by ammonium sulfate precipitation [8].
125! labelled preparations of both IgGl and IgG2b antibodies
demonstrated a single peak of radioactivity on isokinetic su-
crose gradients [6] and were >95% precipitable with 10%
trichloroacetic acid (TCA).
Experimental model
Twenty mg/kg of DNP-GL was injected, via tail vein, in
Sprague-Dawley rats. Two hours after the injection of antigen,
rats were injected i.v. with 10 mg of either purified precipitating
IgGi (N 6) or purified nonprecipitating IgG2b (N = 6)
anti-DNP antibodies. In some experiments, rats received injec-
tions of mixtures of precipitating and nonprecipitating anti-DNP
antibodies (N = 5). Control rats (N = 13) received either
DNP-GL alone (N = 7) or anti-DNP antibodies alone (N = 6).
We have previously demonstrated that less than 2% of the
injected dose of DNP-GL remains in the circulation two hours
after i.v. injection. At the same time, a significant amount of the
antigen remains localized in the glomerular mesangium [5].
Thus, the experimental protocol used in the present study was
designed to produce in situ immune complex formation in the
glomerulus.
At different times after injection of anti-DNP antibodies,
kidney biopsies were obtained. Portions of tissue were fixed in
10% formaldehyde or 2% glutaraldehyde and processed for light
microscopy or transmission electron microscopy, respectively.
Another portion of kidney tissue was kept frozen at —70°C in
isopenthane and stained, by immunoperoxidase, for the pres-
ence of mouse immunoglobulins. Four micron cryostat sections
of kidney biopsy tissue was incubated sequentially with the
following reagents: avidin-biotin blocking solution (Vector Lab-
oratories, Incline Village, Nevada, USA), biotinylated rat-
absorbed horse anti-mouse Ig (Vector), avidin-biotin-peroxi-
dase complexes (Vector), and peroxidase substrate (AEC,
Sigma Chemical Co., St. Louis, Missouri, USA). In some
cases, tissues were counterstained with hematoxylin. Two hour
biopsies from rats injected with DNP-GL followed by combi-
nations of precipitating and nonprecipitating antibodies were
stained with biotin labelled rat monoclonal anti-mouse IgGl or
anti-mouse IgG2b (Zymed). Subsequently, tissues were incu-
bated with peroxidase labelled strepavidin (Vector) and perox-
idase substrate (AEC).
In some experiments, the infusion of DNP-GL was followed
by injection of 1251 IgGi precipitating (N = 5) or 125! IgG2b
nonprecipitating antibodies (N = 6). The total amount of
antibody injected was 10 mg per rat. Control rats were injected
with radiolabelled antibodies alone (N = 3 in each group).
Blood samples were obtained by tail vein clipping at 2, 5, 15, 30,
60 and 120 minutes after injection of antibody. These samples
were counted for radioactivity before and after precipitation
with 10% TCA, to separate nonprotein bound 125! and results
were expressed as percent of the injected dose (ID) per ml of
blood. The presence of circulating IC was evaluated as follows:
plasma samples obtained five minutes after injection of radio-
labelled antibodies were fractionated by isokinetic sucrose
gradient centrifugation [6] to determine the size of the circulat-
ing antibody. All rats injected with radiolabelled antibodies
were sacrificed two hours after injection of antibody. Kidney
biopsies were performed at the time of sacrifice in rats injected
with DNP-GL and 125! IgGi (N = 3) or 1251 IgG2b (N = 4). Both
kidneys were removed from all rats and glomeruli were isolated
by differential sieving. The number of glomeruli and the purity
of the glomerular preparation were determined by microscopy
and the radioactivity contained in the glomerular preparation
was counted. Results were expressed as pg of antibody per i0
glomeruli, based on the cpm present in the glomerular prepara-
tion and the known specific activity of the radiolabelled anti-
bodies.
Assessment of the binding and release of anti-DNP
antibodies from DNP-GL
The biophysical characteristics of the anti-DNP antibodies
used in the present study has been previously described [6]. To
assess the reactivity of IgGl and IgG2b anti-DNP antibodies
with DNP-GL, 96 wells microtiter plates (Limbro) were coated
nonspecifically with DNP-GL [9]. After washing, wells were
incubated with increasing concentrations of purified IgGi or
IgG2b anti-DNP antibodies. The amount of mouse antibody
bound to the well was determined by subsequent incubation
with peroxidase labelled goat anti-mouse antibodies (Tago)
followed by peroxidase substrate (OPD, Sigma). Color devel-
opment was measured at 490 nm in an ELISA reader (Bio-Tek
Instruments, Burlington, Vermont, USA). Results were ex-
pressed as the concentration of anti-DNP antibody (/Lg/ml)
which gave half maximum O.D. reading.
To determine the dissociation rate of IgG 1 and IgG2b anti-
DNP antibodies from DNP-GL, the following experiments were
performed: 125! IgGl or 1251 IgG2b (0.5 g) were incubated with
10 jd of DNP-GL bound to Sepharose 4B (Pharmacia) (DNP-
GL Sepharose). The dose of antibody used was determined
previously to give maximum binding of antibody to the DNP-
GL Sepharose, After a 60 minute incubation at 37°C, bound and
free antibody were separated by centrifugation and washing.
Nonspecific binding was calculated after incubation of 125!
antibody with DNP-GL Sepharose in the presence of 500-fold
excess of nonradiolabelled antibody of the same isotype. Non-
specific binding represented 19% of the total IgGi binding and
22% of the total IgG2b binding. DNP-GL Sepharose containing
bound 1251 antibody was resuspended in 3 ml of PBS containing
20 p.g/ml of nonlabelled antibody of the same isotype than that
bound to the sepharose. After incubation at 37°C for various
periods of time the DNP-GL Sepharose was separated by
centrifugation and washing and bound counts measured. The
antibody dissociation rate (%/240 mm) was calculated by the
following formula: [(cpm bound at time 0 — cpm bound at 240
min)/cpm bound at time 0] x 100.
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To evaluate the interactions between IgGI and IgG2b anti-
bodies, DNP-GL Sepharose was incubated with 1251 IgGi in the
presence of nonlabelled IgGi or IgG2b. Similar experiments
were done using 125J IgG2b as the primary antibody. Results
were expressed as percent inhibition of binding: (Binding in the
presence of inhibitor/Binding in the absence of inhibitor) x 100.
To evaluate the effect of IgG2b on the dissociation of IgG 1 from
antigen, DNP-GL Sepharose was incubated with 1251 IgGi in
the presence of 10-fold excess of either nonlabelled IgGi or
nonlabelled IgG2b. The release rate of 125! IgGl from the
Sepharose was calculated as described above. Similar experi-
ments were done to evaluate the effect of IgGi on the dissoci-
ation of 125! IgG2b from DNP-GL Sepharose.
Assessment of the reactivity of anti-mouse IgG antibodies
with Gi and G2b anti-DNP antibodies
To compare the reactivity of biotinylated horse anti-mouse Ig
antibody (the secondary antibody used for staining tissues) with
mouse IgGi versus mouse IgG2b, a modified ELISA was used.
Known concentrations of 125j labelled IgGI and 125j IgG2b
anti-DNP antibodies were diluted in carbonate buffer, pH 9.6
and incubated, for one hour at room temperature and overnight
at 4°C, in 12 x 75 polystyrene tubes. After washing, the
radioactivity bound to the tube was counted in a gamma-
scintillation counter. Subsequently, a constant amount of biot-
inylated horse anti-mouse Ig was added and incubated for 30
minutes at room temperature. The amount of horse antibody
bound to the tubes was determined after incubation with
avidin-biotin-peroxidase complexes and peroxidase substrate
(D-phenylenediamine, Sigma) as described above. Superna-
tants were transferred to ELISA plates and color development
was quantitated by absorption at 490 nm.
Quantitation of glomerular antibody deposition by
Computerized Image Analysis (CIA)
For these studies, all cryostat sections of kidney tissue were
stained simultaneously by the immunoperoxidase method de-
scribed above, maintaining all the incubation times constant for
all sections. These tissue sections were not counterstained with
hematoxylin.
For CIA analysis, tissue sections were examined by light
microscopy at Mx magnification. A black and white video
camera (Dage-MTI, series 86) was connected directly to the
microscope. This video camera provided a visual signal which
was fed through a real time video processor (Nippon Avionics,
model Image E) to a computer (Magiscan 2A, Joyce-Loebl) for
subsequent digitization and analysis. The image was displayed
on a black and white video monitor. The video amplification
was adjusted so that the computer would assign a value of 0%
for the density of areas judged as having no specific immuno-
staining, in the most negative tissues and a value of 100% for the
areas observed to have the densest immunoperoxidase staining,
in the most positive tissues, After digitizing the video signal, the
computer was instructed to analyze only glomeruli, selected
with the help of a light pen. The following measurements were
generated by the computer: total glomerular area (jim2), area of
the glomerulus occupied by peroxidase positive material (jim2),
and average optical density of the glomerulus (OD units).
Results are reported throughout the manuscript as the percent
of glomerular area occupied by peroxidase positive material
[(peroxidase positive area/total glomerular area) x 100] and as
glomerular optical density divided by the total glomerular area
(OD/jim2). In each sample a minimum of six glomeruli per
section were analyzed, and values reported for that section
represent the mean of all the individual glomerular measure-
ments.
To assess the correlation between the amount of mouse
immunoglobulin deposited in glomeruli and CIA measurements,
the following experiment was performed. Normal human kid-
ney sections were incubated with increasing concentrations of
125J labelled mouse IgGi monoclonal anti-complement receptor
type I (CR1) antibody (Eli) [10]. We selected this antigen-
antibody system because in the normal human kidney, CR1 is
present exclusively in glomerular visceral epithelial cells [11].
Thus, the amount of specific radioactivity bound to the tissue
section can be assumed to represent radioactivity bound to
glomeruli. The concentrations of Ell antibody used were
selected to give immunoperoxidase staining of glomeruli rang-
ing from negative to 4+, by light microscopy. After incubation
with 1251 labelled El 1 tissue sections were incubated with
biotinylated horse anti-mouse Ig, avidin-biotin-peroxidase com-
plexes and peroxidase substrate (see above). Radiolabelled and
peroxidase stained tissue sections were first analyzed by CIA
and simultaneously the number of glomeruli per section was
determined. Subsequently, glass slides were cut and tissues
were counted in a gamma scintillation counter to determine the
amount of radiolabelled mouse antibody bound to the section.
Nonspecific binding of 125! mouse anti-CR! antibody was
determined in kidney sections incubated with this antibody in
the presence of 100-fold excess of nonradiolabelled antibody.
Nonspecific binding represented a mean of 13% of the total
binding and was subtracted from the total binding to determine
the specific binding.
Antigen deposition and removal from kidney
To assess for the presence of DNP-GL in the kidney, 20
mg/kg of 125! DNP-GL was injected intravenously into nine
rats. Two hours later, precipitating IgGl (N 3) or nonprecip-
itating IgG2b (N = 3) anti-DNP antibodies were injected i.v. At
1, 6, 24, 72 hours and 7 days after injection of antibody, kidney
biopsies were performed and the tissue was weighed. The
radioactivity in the biopsy was measured in a gamma counter
and results were expressed as the percent of the injected dose of
antigen per gram of renal tissue (%ID/g). Control rats received
only 125! DNP-GL (N = 3) and were biopsied at 3, 8, 24, 72
hours and 7 days after injection of antigen.
Analysis of data
Numerical values are expressed as means standard error of
the mean. Data was analyzed by Student's t-test, paired t-test
and linear regression by least square analysis.
Results
Quantitation of glomerular antibody deposition by CIA
Normal human renal tissues were stained, by immunoper-
oxidase, with 1251 mouse monoclonal anti-CR1 antibody fol-
lowed by horse anti-mouse 1g. The amount of mouse antibody
in the tissue was quantitated both by measurement of radioac-
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Eli bound/glomerulus, pg
Fig. 1. Relationship between radioactive measurements of glomerular
125J mouse anti-CR1 antibody (Eli) (X axis) and glomerular optical
density measured by CIA (Y axis). A. Data on the X axis expressed on
a linear scale. It can be seen that glomerular optical density values
reach a maximum at approximately 13 pg of El 1/glomerulus. B. Same
data demonstrated on panel A after logarithmic transformation of the X
axis. Note the sigmoidal relationship between the two measurements of
glomerular antibody concentration.
tivity (cpm) and by CIA quantitation of glomerular optical
density (OD4Lm2). Figure 1 depicts the results of these exper-
iments. It can be observed that glomerular optical density
readings reach a plateau when the amount of mouse Ig in the
tissue was approximately 13 pg/glomeruli (Fig. 1A). When the
data was expressed on a logarithmic X axis, it can be seen that
the relationship between the amount of antibody in glomeruli
and the glomerular optical density is sigmoidal (Fig. 1B). This
type of relationship is similar to that observed between amount
of protein and peroxidase as assessed by ELISA [9, 12]. Thus,
CIA permits quantitation of glomerular antibody deposition and
the CIA measurement of glomerular optical density demon-
strates a linear correlation with the amount of antibody in the
glomerulus, within a limited range. Above and below the linear
range, glomerular optical density correlates still with antibody
concentration by it is an insensitive index. It should be men-
tioned that the glomerular optical density is significantly dif-
ferent between unstained human (3.9 0.2 ODIm2, N 5)
and rat (0.7 .2 OD/m2, N 9; P < 0.0001). Thus, the
standard curve generated above in human tissues (Fig. 1)
should not be used to derive the actual pg of antibody present in
rat tissue.
We also compared the intensity of immunoperoxidase stain-
ing, assessed by CIA, to a standard semiquantitative light
microscopy method that scores staining intensity from 1 + to
4+. For this analysis, renal tissues from all rats injected with
DNP-GL and monoclonal anti-DNP antibodies were analyzed.
CIA data were expressed as glomerular optical density and as
percent peroxidase positive area. This second parameter can be
obtained only in those tissues that contained peroxidase posi-
tive material visible by light microscopy. Results are demon-
strated in Figure 2. First, light microscopic immunoperoxidase
scores correlated significantly with glomerular optical density (r
0.769, P < 0.001; Fig. 2A). It should be noted that some
tissues negative for immunoperoxidase by light microscopy
(peroxidase score = 0) demonstrated a values of glomerular
optical density greater than 2 standard deviations above the
mean of normal glomeruli (N = 9, 0.7 0.6 SD). This is better
appreciated when a logarithmic scale for the X axis is used (Fig.
2B). Second, in those tissues containing visible peroxidase
positive material, there was a significant positive linear relation-
ship between the immunoperoxidase score and the logarithm of
the peroxidase positive glomerular area (r = 0.911, P < 0.001;
Fig. 2 C and D). Thus, quantitation of peroxidase positive area
provides a measurement of glomerular immunoprotein on a
broader scale than light microscopic semiquantitative methods.
In conclusion, measurement of glomerular optical density per-
mits an analysis of those tissues negative for peroxidase by light
microscopy. Measurement of peroxidase positive glomerular
area permits a more accurate analysis of those glomeruli
strongly positive for peroxidase by light microscopy.
Reactivity of anti-DNP antibodies and of anti-mouse Ig
antibodies
The binding of precipitating IgG 1 and nonprecipitating IgG2b
anti-DNP antibodies to DNP-GL was evaluated by ELISA.
IgG2b demonstrated significantly higher anti-DNP antibody
titer than IgGi (N 5; IgG1 mean 0.36 0.02 p.g/ml standard
error and IgG2b 0.63 0.09 gIml, P < 0.05). By contrast, the
dissociation rate of IgG2b antibodies from DNP-GL Sepharose
(73 7 %1240 mm) was significantly faster than the dissociation
rate of IgGl antibodies (43 8 %1240 mm) (N = 6 both, P =
0.0002).
The reactivity of biotin-labelled horse anti-mouse Ig with
mouse IgG1 and IgG2b anti-DNP antibodies is shown in Figure
3. As can be seen, there are no statistically significant differ-
ences in the reactivity of horse anti-mouse Ig with mouse IgG 1
or mouse IgG2b.
Glomerular deposition of precipitating and nonprecipitating
antibodies. Quantitation by CIA
The amount of peroxidase in glomeruli was first analyzed by
light microscopy (Fig. 4) and the results were expressed as
peroxidase scores. These data is summarized in Figure 5A.
Glomerular antibody deposition, two hours after injection, was
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Fig. 3. Binding of biotin-labelled horse anti-mouse Ig to polystyrene
tubes coated with variable amounts of 125j mouse IgGI anti-DNP
antibodies (0) or 125j mouse IgG2b anti-DNP antibodies (•). The
amount of mouse IgG bound to the tube was measured by radioactive
counts. The amount of horse antibody bound to the tube was measured
on an ELISA reader at 490 nm, after peroxidase development (Meth-
ods). The two lines in the graph represent computer generated logarith-
mic relation of the data with an r value of 0.960 for IgGi and 0.970 for
IgG2b.
not significantly different between animals injected with precip-
itating or nonprecipitating antibodies. However, six hours after
injection, more antibody appeared to be present in the glomeruli
of those animals injected with precipitating antibodies.
The same tissues analyzed by light microscopy were ana-
lyzed by CIA. Quantitation of the percent of glomerular area
positive for peroxidase confirmed the results obtained by light
microscopy (Fig. 5B). Thus, no statistically significant differ-
ences in peroxidase positive area were demonstrated in two-
hour kidney biopsies of rats injected with precipitating or
nonprecipitating antibodies. However, at six hours, a signifi-
cantly larger area of glomeruli was occupied by peroxidase
positive material in rats injected with precipitating IgGi anti-
bodies than in rats injected with nonprecipitating IgG2b anti-
bodies (P = 0.014). At 24 hours, peroxidase positive material
was demonstrated only in the glomeruli of rats injected with
precipitating antibodies. At 48 hours, neither group of rats had
detectable peroxidase positive glomerular material. Measure-
ment of glomerular optical density permitted us to evaluate
biopsy tissues obtained 24 and 48 hours after injection of
antibodies (Fig. SC). Compared with rats injected with nonpre-
cipitating antibodies, rats injected with precipitating antibodies
demonstrated significantly higher glomerular optical density in
biopsies obtained 6, 24, and 48 hours after antibody injection.
Furthermore, in 48 hour biopsies, the glomerular optical density
was significantly higher in animals injected with precipitating
antibodies than in control animals injected with antigen alone,
antibody alone or not injected (Fig. SC). In summary, the initial
deposition of antibody in the glomerulus is not dependent on the
precipitating characteristics of the antibody. However, precip-
itating antibodies remain in the glomerulus for longer periods of
time than nonprecipitating antibodies.
Tissue specimens were also evaluated for evidence of gb-
merulonephritis. By light microscopy, the only abnormality
observed was the presence of inflammatory cells, mainly PMN,
in two and six hour biopsies of animals injected with antigen
and either precipitating or nonprecipitating antibody. By elec-
tron microscopy we did not detect electron dense deposits in
any of the experimental groups. A more complete description of
the microscopic findings that occur during the course of this
experimental model of gbomerulonephritis is the subject of a
separate report [13].
Quantitation of precipitating and nonprecipitating antibody
deposition in glomeruli using radiolabelled antibodies
To assess for the formation of circulating IC, plasma samples
obtained five minutes after injection of labelled antibody were
analyzed by sucrose gradient centrifugation. There were no
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Fig. 4. Light microscopy of immunoperoxidase stained tissuCs from rats injected with DNP-GL followed by IgGI precipitating antibodies (top
row) or IgG2b nonprecipitating antibodies (bottom row). A and D, 2 hour biopsies; B and E, 6 hour biopsies; C and F, 24 hour biopsies.
significant differences in the size of circulating antibody be-
tween rats injected with 125j IgG2b antibody alone or 1251 IgG2b
antibody following DNP-GL infusion. Compared to rats in-
jected with 125J IgGi alone, rats injected with 125J IgGl follow-
ing DNP-GL demonstrated 2% of the circulating antibody as
>25S material. Thus, using the present experimental protocol,
the majority of anti-DNP antibodies circulate as free antibody.
In rats injected with DNP-GL, two hours after injection of
125J antibodies there were no significant differences in blood
levels of IgGi antibodies (3.6 0.4% ID/rnl) and IgG2b
antibodies (2.9 .3% ID/mI). Measurement of radioactivity
present in isolated glomeruli two hours after injection of radio-
labelled antibodies demonstrated the following findings. Com-
pared to rats injected with antibodies alone, the glomerular
deposition of both IgG 1 precipitating and IgG2b nonprecipitat-
ing antibodies was significantly enhanced in rats injected first
with DNP-GL (IgGi alone, 135 10 pg/104 glomeruli vs. IgGi
following DNP-GL, 701 110 pg/b4 glomeruli; IgG2b alone,
291 83 pg/b4 glomeruli vs. IgG2b following DNP-GL, 794
85 pg/l04 glomeruli). However, the glomerular deposition of
IgGl anti-DNP (701 110 pg/b4 glomeruli) and IgG2b anti-
DNP antibodies (794 85 pg/104 glomeruli) was not signifi-
cantly different in rats injected with DNP-GL prior to the
injection of antibody. Thus, in agreement with the results of
CIA analysis, the initial glomerular deposition of precipitating
and nonprecipitating antibodies is not significantly different.
Antibody deposition was also analyzed by CIA in two-hour
kidney biopsies from seven rats injected with DNP-GL and 125J
antibodies (3 IgGI and 4 IgG2b). The peroxidase positive area
(IgGl, 2.2 .4%; IgG2b, 2.5 .9%) and the glomerular optical
density (IgGl, 17 2 OD/tm2; IgG2b, 21 3 OD/tm2) were
not significantly different, thus confirming previous observa-
tions (Fig. 5). The relationship of these CIA measurements with
glomerular antibody levels measured by readioactive counts
was evaluated. Increasing amounts of 1251 antibody in glomeruli
were associated with increasing percent glomerular peroxidase
positive area (r = 0.912, P < 0.01) and increasing values for
glomerular optical density (r = 0.822, P < 0.05). These data
confirm that CIA measurements reflect glomerular antibody
levels.
Rate of removal of DNP-GL from the kidney of rats injected
with precipitating or nonprecipitating antibodies
Figure 6 demonstrates the results of these studies. There
were no significant differences in the rate of removal of 1251
DNP-GL from the kidneys of rats injected with this antigen
followed by precipitating or nonprecipitating antibodies. How-
ever, compared to rats injected with 1251 DNP-GL alone, rats
injected with this antigen and antibody, as a group, demon-
strated higher antigen levels in the kidney, at 6 and 24 hours.
Thus, the binding of anti-DNP antibodies to DNP-GL deposited
in the glomerulus delays significantly the removal of DNP-GL
from the glomerulus, whether precipitating or nonprecipitating
antibodies are bound.
Glomerular deposition of anti-DNP antibodies when mixtures
of precipitating and nonprecipitating antibodies are
administered simultaneously
We previously demonstrated that antibody preparations com-
posed of equal amount of precipitating IgG 1 and nonprecipitat-
ing IgG2b anti-DNP antibodies do not precipitate antigen [6].
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represents the mean + 2 5D of glomerular optical density values in
tissues from rats injected with DNP-GL alone or anti-DNP antibodies
alone. Data represents means standard error.
To assess the in vivo behavior of these mixtures of antibodies,
rats were injected with DNP-GL followed, two hours later, by
injection of 10 mg of a mixture of anti-DNP antibodies com-
posed of 5 mg of IgGl and 5 mg of IgG2b. By immunoper-
oxidase we demonstrated that two hours after injection of the
IgGl/IgG2b antibody mixture both antibodies were deposited in
glomeruli. Figure 7 displays glomerular antibody levels after
injection of IgG lIIgG2b antibody mixtures and after injection of
pure preparations of IgGi or IgG2b. Compared to animals
injected with precipitating IgGi antibodies, glomerular anti-
Time, hours
Fig. 6. Persistence of the antigen 125j DNP-GL in the kidneys of rats
injected with antigen alone (U), rats injected with 125j DNP-GL
followed by precipitating IgGi anti-DNP antibodies (0) and in rats
injected with 125j DNP-GL followed by nonprecipitating IgG2b anti-
DNP antibodies (•). Antigen levels in the kidney are expressed in the
Y axis as the % of the injected dose of antigen per gram of renal tissue
(% ID/g). Values represent means standard error of the mean. (* P <
0.05 and +P < 0.005 compared to the group of rats injected with 1251
DNP-GL followed by anti-DNP antibodies).
body levels were significantly lower at 6, 24 and 48 hours after
injection of the mixture of precipitating and nonprecipitating
antibodies. In addition, there were no significant differences, at
two and six hours, on glomerular antibody deposition between
animals injected with nonprecipitating IgG2b antibodies or
mixtures of IgGl and IgG2b antibodies.
The above in vivo results may indicate that IgG2b inhibits the
binding of IgGi to glomeruli and/or that IgG2b accelerates the
removal of IgGi from glomeruli. To assess these possibilities
we evaluated the interactions of IgG 1 and IgG2b antibodies in
vitro. Incubation of 125! IgGl with DNP-GL Sepharose in the
presence of increasing concentrations of IgG2b resulted in
progressive inhibition of binding. At ratios of IgGi to IgG2b
similar to those used in vivo (1:1), IgG2b caused a 12 2%
inhibition of the binding of IgGl to DNP-GL. By contrast, the
rate of dissociation of IgG 1 bound to DNP-GL was not affected
by IgG2b. Thus, the dissociation rate of 125j IgGl was the same
when this antibody bound to DNP-GL in the presence of
nonlabelled IgG 1 or equal amounts of nonlabelled IgG2b anti-
bodies (Fig. 8). Similarly, IgGi did not significantly affect the
rate of dissociation of IgG2b bound to DNP-GL. In conclusion,
IgG2b inhibits the binding of IgG 1 to DNP-GL but it does not
affect its rate of dissociation from the antigen.
Discussion
In the present study we used well-characterized monoclonal
anti-DNP antibodies [6], that were either precipitating or non-
precipitating, to assess the effect of antibody precipitating
characteristics on the formation of glonierular IC. We demon-
strated that the initial localization of antibody in the glomerulus
is not quantiatively different for precipitating or nonprecipitat-
ing antibodies. However, over time, significantly more precip-
itating antibody remained in glomeruli. When precipitating and
nonprecipitating antibodies were administered simultaneously,
the net effect was to abrogate the ability of precipitating
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Time, hours
Fig. 7. Peroxidase positive glomerular area (A) and glomerular optical
density (B) in rats injected with DNP-GL followed by 10 mg of
precipitating IgGI anti-DNP antibodies (open bars), JO mg of nonpre-
cipitating IgG2b anti-DNP antibodies (hatched bars) and 5 mg of IgGi
+ 5 mg of IgG2b anti-DNP antibodies (closed bars). Horizontal line in
panel B represents the mean + 2 SD of glomerular optical density values
in tissues from rats injected with DNP-GL alone or anti-DNP antibodies
alone. (* P < 0.001, +P < 0.05 compared to values in rats injected with
IgGi antibodies, **p < 0.05 compared to values in rats injected with
IgG2b antibodies).
antibody to remain longer in glomeruli. This suggests that in
vivo, nonprecipitating antibodies compete with precipitating
antibody for the antigen.
In the present study we used Computerized Image Analysis
(CIA) to analyze tissue sections stained by immunoperoxidase.
We found that CIA provides numerical data that correlates with
the amount of antibody deposited in glomeruli. The relationship
between the actual amount of antibody deposited in glomeruli
and CIA measurements of immunoperoxidase is described by a
sigmoidal curve similar to that generated during ELISA (Fig.
lB). It follows that to accurately quantitate the amount of
antibody in tissue by CIA, data points should be contained in
the linear region of the correlation curve, that is, below maxi-
mum optical density (Fig. 1 A and B). We showed that the CIA
scale for peroxidase intensity is broader than the light micros-
copy scale. Thus, the upper limit of CIA measurements is
Time, minutes
Fig. 8. Release of 125j IgGI (solid lines) and 125j IgG2b (dashed lines)
from DNP-GL Sepharose. Radiolabelled antibodies were bound to
DNP-GL Sepharose in the presence of excess nonlabelled antibody of
the same isotype (•, U) or excess antibody of the opposite isotype (0,
0). After binding, sepharose beads were washed, resuspended in PBS
and reincubated at 3TC for variable periods of time (X axis). Sepharose
beads were then separated by centrifugation, washed and counted for
radioactivity. The amount of antibody bound to the Sepharose after the
initial incubation was considered as 100% and subsequent values as the
percent of that initial value (Y axis).
significantly higher than the upper limit of light microscopic
peroxidase scores (4+) (Fig. 2 A and B). To insure that the CIA
analysis in the present study was performed in the linear part of
the correlation, we titrated the immunoperoxidase staining to
give below maximum staining by light microscopy in the most
positive tissues. That this goal was achieved is demonstrated in
experiments using radiolabelled anti-DNP antibodies where we
demonstrated that the CIA values reported here accurately
reflect glomerular antibody levels.
Compared to semiquantitative light microscopic examina-
tion, CIA analysis of tissues has several advantages: First, CIA
provides a numerical value of peroxidase intensity (or any other
stain for that matter) which can be analyzed statistically;
Second, provided that immunoperoxidase staining is main-
tained below saturation, CIA provides actual quantitation of
antibody in glomeruli; Third, CIA measurements expand the
analyzable stain-intensity scale both below and above the range
of light microscopic scores. Finally, quantitation of immuno-
proteins in tissues by CIA avoids the use of radioactive mate-
rials.
Two characteristics of the experimental model used here are
particularly important for the interpretation of the results: First,
in this model, glomerular IC form by in situ mechanisms [5, 13];
Second, the removal of antigen from the kidney is not signifi-
cantly affected by the precipitating properties of the antibodies.
This latter observation is most likely due to the fact that
DNP-GL has a high binding affinity for glomerular fibronectin
[5]. Thus, given the characteristics of the experimental model
used here, we believe that the faster removal of nonprecipitat-
ing antibodies from the glomerulus is most likely due to the
intrinsic binding characteristics of nonprecipitating antibodies
with antigen. We demonstrated that in vitro, nonprecipitatirig
antibodies dissociate faster from DNP-GL than precipitating
antibodies. Interactions between the Fc regions of antibodies
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bound to antigen in close proximity are important in the
formation of stable IC [14]. We previously postulated [6] that
differences in Fc/Fc interactions between precipitating and
nonprecipitating antibodies may explain differences in the for-
mation of IC by those antibodies. The present results are in
agreement with previous studies in which Agodoa, Gauthier
and Mannik [4] demonstrated similar initial deposition and a
faster removal of antibody from the glomeruli when a nonpre-
cipitating IC system was utilized. The similarity between these
studies is of interest because in the former study nonprecipitat-
ing IC were produced by modifications of the antigen [4] and not
by modification of the antibody as it was done in the present
study.
In a variety of effector systems, it has been demonstrated that
nonprecipitating antibodies can compete with precipitating an-
tibody for antigen binding. For example, we demonstrated that
nonprecipitating antibodies inhibit antigen precipitation and
solubilize IC precipitates [6]. Other authors have demonstrated
that nonprecipitating antibodies inhibit complement activation
and opsonization of antigen by precipitating antibodies [15]. In
the present study we demonstrate that nonprecipitating anti-
bodies can compete with precipitating antibodies for antigen
binding both in vitro and in vivo. This competition may be the
explanation for the present observation that mixtures of precip-
itating and nonprecipitating antibodies result in glomerular
antibody deposition and removal rates similar to those observed
when using pure preparations of nonprecipitating antibodies.
Previous experiments indicate that animals that produce only
nonprecipitating antibodies do not develop acute glomerulone-
phritis but may develop chronic glomerulonephritis [1, 2]. The
findings of the present study provide a reasonable explanation
for those observations. That is, the nephritogenic potential of
nonprecipitating antibodies may be lowered by the fact that
nonprecipitating antibodies dissociate from antigen more easily
than precipitating antibodies. Thus, it may be that only after
long term exposure to a nonprecipitating antibody system, does
sufficient IC formation occur to produce glomerulonephritis. In
rabbit models of chronic serum sickness, approximately 10% of
animals develop a nonprecipitating antibody response [1, 2].
Most commonly, after immunization, 80 to 90% of serum
antibodies are precipitating and 10 to 20% are nonprecipitating
[15]. However, the percent of nonprecipitating antibodies may
be increased by the method of immunization [16]. The present
results suggest that the ratio of precipitating to nonprecipitating
antibodies in the circulation may be a determinant of the
pathogenicity of the antibody response.
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